CURTISS WRIGHT CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CURTISS WRIGHT CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.39B | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $2.49B | Feb 25, 2021 |
| FY2020 | Dec 31, 2018 | $2.41B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $2.27B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $2.11B | Feb 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.50B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.12B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $2.85B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $2.56B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $2.50B | Feb 20, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $611.88M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $567.90M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $567.65M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $523.59M | Feb 22, 2018 |
| FY2016 | Dec 31, 2016 | $565.57M | Feb 21, 2017 |
| FY2016 | Sep 30, 2016 | $507.09M | Feb 21, 2017 |
| FY2016 | Jun 30, 2016 | $532.77M | Feb 21, 2017 |
| FY2016 | Mar 31, 2016 | $503.51M | Feb 21, 2017 |
| FY2015 | Dec 31, 2015 | $588.76M | Feb 25, 2016 |
| FY2015 | Sep 30, 2015 | $525.54M | Feb 25, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.07B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $954.61M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $927.80M | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $241.80M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $212.82M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $186.03M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $200.58M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $245.75M | Feb 25, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $484.23M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $404.98M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $354.51M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $294.35M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $262.83M | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $53.99M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $64.62M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $31.02M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $51.76M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $89.41M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $633.52M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $528.60M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $484.60M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $423.44M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $377.13M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $288.85M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $403.95M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $373.63M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $325.12M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $296.52M | Feb 27, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $95.16M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $91.65M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $85.76M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $80.84M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $88.49M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $74.82M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $72.52M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $64.53M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $61.39M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $59.42M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $643.40M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $544.28M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $448.09M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $294.78M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $387.67M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $261.18M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $421.40M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $336.27M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $388.71M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $423.20M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $89.69M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $60.97M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $44.67M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $38.22M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $41.11M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $47.50M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $69.75M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $53.42M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $52.71M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $46.78M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.22B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.99B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $4.62B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $4.45B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $4.10B | Feb 22, 2023 |
| FY2022 | Dec 31, 2020 | $4.02B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $3.76B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $3.26B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $3.24B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $3.04B | Feb 27, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.69B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.54B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.29B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $2.47B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.28B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.23B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.99B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.72B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.71B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.75B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.53B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $2.45B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $2.33B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.98B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.83B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.79B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.77B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.53B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.53B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.29B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.69B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.68B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.56B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.54B | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $1.46B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.46B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $1.17B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.09B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.10B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $951.06M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.31B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.86B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $3.49B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $3.16B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.91B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.67B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.50B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.19B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.94B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.75B | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $171.00M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $198.25M | Feb 24, 2022 |
| FY2021 | Dec 31, 2019 | $391.03M | Feb 24, 2022 |
| FY2021 | Dec 31, 2018 | $276.07M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $475.12M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $553.85M | Feb 27, 2020 |
| FY2018 | Dec 31, 2015 | $288.70M | Feb 27, 2019 |
| FY2017 | Dec 31, 2014 | $450.12M | Feb 22, 2018 |
| FY2016 | Dec 31, 2013 | $175.29M | Feb 21, 2017 |
| FY2015 | Dec 31, 2012 | $112.02M | Feb 25, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $957.88M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.05B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.05B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.25B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.05B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.06B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $760.64M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $762.56M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $814.14M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $966.30M | Feb 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 10 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 9 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 10 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 9 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.86M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 37.65M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 38.20M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 38.26M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 38.47M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 40.92M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 42.68M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 42.77M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 44.12M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 44.18M | Feb 22, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.73M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $31.66M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $30.25M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $28.78M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $28.66M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $28.18M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $28.20M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $26.33M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $24.74M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $23.07M | Feb 27, 2019 |